The global U.S. Human Microbiome Modulators market size reached USD 106.56 Million in 2021 and is expected to reach USD 726.18 Million in 2030 registering a CAGR of 24.3%. U.S. Human Microbiome Modulators market growth is primarily driven owing to increasing investments and funding toward the development of human microbiome modulator products and increase in lifestyle chronic diseases
read more..